Respiratory disease focused Verona Pharma booked a first-half loss, as it ramped up research and development spending.

Pre-tax losses for the six months through June...

Gattaca said it expected underlying pre-tax profits to be slightly above market expectations and net debt also lower than expected levels.

The positive outlook comes...

Goldman Sachs today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5500p (from 5000p).

Broker Forecasts data provided...

Life Settlement Assets detailed plans to buy back a maximum of US$0.5m D shares and up to a maximum of US$0.5m E shares.

'The Buyback...

UK stocks opened lower on Tuesday, extending heavy losses on Friday and Monday, as the pound strengthened and investors digested a slew of local corporate...

Nick Wong, Financial Director, bought 53,500 shares in the company on the 5th August 2019 at a price of 11.85p. The Director now holds 8,962,593...

Andrea Cattaneo, Chief Executive Officer, bought 7,500,000 shares in the company on the 5th August 2019 at a price of 2.50p. The Director now holds...

Michael Tobin, Chairman, bought 4,629 shares in the company on the 5th August 2019 at a price of 215.00p. The Director now holds 144,294 shares....

Christopher Brinsmead, Chairman, bought 1,000 shares in the company on the 2nd August 2019 at a price of 731.90p. The Director now holds 6,000 shares....

Goldman Sachs today reaffirms its sell investment rating on Pearson PLC (LON:PSON) and raised its price target to 696p (from 683p).

Broker Forecasts data provided...